The assay uses arachidonic acid as a substrate to screen for inhibition of 15hLO-1 activity. The extent of hydroperoxide product formation is measured by a secondary chromogenic reaction using xylenol orange and ferric ions, characterized by red-shifted absorbance at 560 nm. A purified preparation of human 15hLO-1 is used in the assay. The enzyme is a candidate for drug development in areas such as cancer and inflammation. Is the molecule effective to this assay?